ABOUT US

Founded in 1975, Kaplan Research and Development, LLC provides clinical research, data management, statistical and reporting services to the pharmaceutical and related industries. 

Kaplan Research and Development maintains a highly-experienced management team and staff with the capabilities to perform a wide range of clinical trials.  Although most studies are conducted with oral dosage formulations, Kaplan Research and Development has developed expertise in performing studies with non-traditional delivery systems such as topical transdermal, nasal, inhaled, and intravenous routes of administration. Kaplan Research and Development is the world leader in vasoconstrictor studies of topical corticosteroids for both generic and innovator drugs. Further, we are a leader in performing pharmocokinetic (PK), irritation, sensitization, and adhesion studies with transdermal and topical dosage forms. 

Kaplan Research and Development’s rapidly growing clinical trials management and data management groups, currently focus on performing studies through IV clinical endpoint studies requiring large patient populations in non-serious disease states that are treated in an outpatient setting. Examples would include many dermatological diseases, allergies, vaccines, and diabetes.

Kaplan Research and Development, LLC